American Academy of Pain Medicine: Opioid Medication Label Change Won’t Solve Prescription Drug Abuse

In written comments to the FDA, the American Academy of Pain Medicine noted that changing the label on opioid pain medications to limit their continuous use to 90 days would do little to stop drug abuse while depriving millions of Americans the medication they need.

Advertisement

AAPM wrote that adopting the proposal to change the label could eliminate the use of opioids for chronic, non-cancer pain, usually defined as lasting beyond 90 days.

More Articles on Pain Management:

University of Michigan Appoints Carmen Green as Associate Dean for Health Equity
Georgia House Passes Pain Clinic Regulation Legislation
Study: Racial Disparities in Opioid Monitoring, Follow-Up Treatment Practices for Chronic Pain

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Uncategorized

Advertisement

Comments are closed.